title: In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto.
abstract: The antifungal susceptibilities of 40 clinical and environmental isolates of A. terreus sensu stricto to amphotericin B, terbinafine, itraconazole, and voriconazole were determined in accordance with CLSI document M38-A2. All isolates had itraconazole and voriconazole MICs lower than epidemiologic cutoff values, and 5% of the isolates had amphotericin B MICs higher than epidemiologic cutoff values. Terbinafine showed the lowest MICs. No significant differences were found when MICs of clinical and environmental isolates were compared.
authors.affiliation: Departamento de Micología, Instituto de Medicina Regional. Universidad Nacional del Nordeste, Resistencia, Argentina.
authors.forename: Mariana S
authors.initials: MS
authors.lastname: Fernández
authors.affiliation: Departamento de Micología, Instituto de Medicina Regional. Universidad Nacional del Nordeste, Resistencia, Argentina.
authors.forename: Florencia D
authors.initials: FD
authors.lastname: Rojas
authors.affiliation: Departamento de Micología, Instituto de Medicina Regional. Universidad Nacional del Nordeste, Resistencia, Argentina.
authors.forename: María E
authors.initials: ME
authors.lastname: Cattana
authors.affiliation: Departamento de Micología, Instituto de Medicina Regional. Universidad Nacional del Nordeste, Resistencia, Argentina.
authors.forename: María de Los Ángeles
authors.initials: Mde L
authors.lastname: Sosa
authors.affiliation: Centro de Micología, IMPAM, CONICET-UBA, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
authors.forename: Cristina A
authors.initials: CA
authors.lastname: Iovannitti
authors.affiliation: Department of Hygiene, Microbiology and Social Medicine, Medical University of Innsbruck, Innsbruck, Austria mariana_f19@hotmail.com.
authors.forename: Cornelia
authors.initials: C
authors.lastname: Lass-Flörl
authors.affiliation: Departamento de Micología, Instituto de Medicina Regional. Universidad Nacional del Nordeste, Resistencia, Argentina.
authors.forename: Gustavo E
authors.initials: GE
authors.lastname: Giusiano
mesh_terms: D000666:Amphotericin B / Q000494:pharmacology*; D000935:Antifungal Agents / Q000494:pharmacology*; D001230:Aspergillus / Q000187:drug effects*; D001393:Azoles / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D009281:Naphthalenes / Q000494:pharmacology*; D000077291:Terbinafine
chemical_list: D000935:Antifungal Agents; D001393:Azoles; D009281:Naphthalenes; D000666:Amphotericin B; D000077291:Terbinafine
references.citation: Antimicrob Agents Chemother. 2009 Feb;53(2):794-5
references.pmid: 19064891
references.citation: J Med Microbiol. 2009 Jul;58(Pt 7):968-70
references.pmid: 19502369
references.citation: J Clin Microbiol. 2009 Oct;47(10):3271-5
references.pmid: 19692558
references.citation: J Clin Microbiol. 2010 Sep;48(9):3251-7
references.pmid: 20592159
references.citation: Indian J Pathol Microbiol. 2011 Jan-Mar;54(1):112-6
references.pmid: 21393890
references.citation: J Clin Microbiol. 2011 Jun;49(6):2243-51
references.pmid: 21508152
references.citation: Antimicrob Agents Chemother. 2011 Nov;55(11):5155-8
references.pmid: 21844312
references.citation: Antimicrob Agents Chemother. 2011 Nov;55(11):5150-4
references.pmid: 21876047
references.citation: Antimicrob Agents Chemother. 2013 Apr;57(4):1583-8
references.pmid: 23318794
references.citation: Mycoses. 2013 Jul;56(4):477-81
references.pmid: 23448599
references.citation: Rev Esp Quimioter. 2013 Jun;26(2):173-88
references.pmid: 23817660
references.citation: Rev Iberoam Micol. 2014 Jul-Sep;31(3):176-81
references.pmid: 24120420
references.citation: J Infect Dis. 2003 Jul 15;188(2):305-19
references.pmid: 12854088
references.citation: J Clin Microbiol. 2003 Aug;41(8):3623-6
references.pmid: 12904365
references.citation: Antimicrob Agents Chemother. 2003 Oct;47(10):3085-8
references.pmid: 14506013
references.citation: J Clin Microbiol. 2003 Dec;41(12):5525-9
references.pmid: 14662934
references.citation: J Antimicrob Chemother. 2004 Jun;53(6):1086-9
references.pmid: 15102749
references.citation: Clin Infect Dis. 2004 Jul 15;39(2):192-8
references.pmid: 15307028
references.citation: J Clin Microbiol. 1999 Jul;37(7):2343-5
references.pmid: 10364610
references.citation: Br J Haematol. 2005 Oct;131(2):201-7
references.pmid: 16197450
references.citation: J Med Microbiol. 2006 Jul;55(Pt 7):809-18
references.pmid: 16772406
references.citation: Haematologica. 2006 Jul;91(7):986-9
references.pmid: 16757415
references.citation: Int J Antimicrob Agents. 2007 Jan;29(1):108-11
references.pmid: 17189101
references.citation: Antimicrob Agents Chemother. 2007 Sep;51(9):3329-37
references.pmid: 17576838
references.citation: Antimicrob Agents Chemother. 2008 Apr;52(4):1553-5
references.pmid: 18268082
references.citation: Mycologia. 2008 Mar-Apr;100(2):205-26
references.pmid: 18595197
references.citation: Clin Microbiol Infect. 2008 Dec;14(12):1146-51
references.pmid: 19076844
references.citation: J Chemother. 2008 Dec;20(6):756-7
references.pmid: 19129077
references.citation: J Hosp Infect. 2000 Sep;46(1):31-5
references.pmid: 11023720
references.citation: J Clin Microbiol. 2001 Mar;39(3):954-8
references.pmid: 11230410
references.citation: Antimicrob Agents Chemother. 2001 Jun;45(6):1882-5
references.pmid: 11353643
references.citation: N Engl J Med. 2002 Jan 24;346(4):225-34
references.pmid: 11807146
references.citation: N Engl J Med. 2002 Aug 8;347(6):408-15
references.pmid: 12167683